Search
Avalyn Pharma Ord Shs (Proposed)
AVLNAdd to Watchlist
29.270USD
-0.900-2.98%
Market hours （ET）Quotes delayed by 15 min
36.07MMarket Cap
--P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
59.000
Target Price
+79.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Avalyn Pharma Ord Shs (Proposed)
AVLN
4
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is the analyst rating for Avalyn Pharma Ord Shs (Proposed)?
Based on the ratings of Avalyn Pharma Ord Shs (Proposed)'s stock from 4 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.